SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRamsdens Hldgs Regulatory News (RFX)

Share Price Information for Ramsdens Hldgs (RFX)

Share Price is delayed by 15 minutes
Get Live Data
442.50    7.50 (1.72%)
Bid:
440.00
Ask:
445.00
Spread: 5.00 (1.136%)
Market Cap: £143.17m
RFX Live PriceLast checked at - London Stock Exchange

Intraday Ramsdens Hldgs Share Chart

Director/PDMR Shareholding - CSOP scheme update

24 Jun 2022 14:12

RNS Number : 1710Q
Ramsdens Holdings PLC
24 June 2022
 

 

24 June 2022

 

Ramsdens Holdings PLC

("Ramsdens", the Group, or the "Company")

Director/PDMR Shareholding - CSOP scheme update

 

Ramsdens, the diversified financial services provider and retailer, announced on 17 March 2022, that the Company would implement a Company Share Option Plan (the "CSOP") for 20 Senior Managers within the Group for a total of 110,000 shares. 

The CSOP award was subject to HMRC approval which has now been obtained. Accordingly, the CSOP was implemented on 23 June 2022 with an exercise price of 200.5 pence per share. All other aspects of the scheme remain unchanged.

The only PDMR to be granted options under the CSOP is Jason Carr and the details of his award are below.

 

1.  

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jason Carr

2.  

Reason for the notification

a)

Position/status: IT Director

b)

Initial notification/Amendment: Initial Notification

3.  

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Ramsdens Holdings PLC

b)

LEI: 2138009OAUOROKMFPK95

4.  

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Options over Ordinary shares of 1p each.

Identification code: GB00BDR6V192

b)

Nature of the transaction:

Grant of options pursuant to CSOP

c)

 

 

Price(s) and volume(s):

Price(s)

Volume(s)

200.5p

5,500

d)

Aggregated information:

N/A

 

e)

Date of the transaction: 23 June 2022

f)

Place of the transaction: Outside a trading venue

 

Enquiries:

Ramsdens Holdings PLC Tel: +44 (0) 1642 579957

Peter Kenyon, CEO

Martin Clyburn, CFO

 

Liberum Capital Limited (Nominated Adviser) Tel: +44 (0) 20 3100 2000

Richard Crawley

Lauren Kettle

 

Hudson Sandler (Financial PR) Tel: +44 (0) 20 7796 4133

Alex Brennan

Lucy Wollam

 

About Ramsdens

Ramsdens is a growing, diversified, financial services provider and retailer, operating in the four core business segments of foreign currency exchange, pawnbroking loans, precious metals buying and selling and retailing of second hand and new jewellery. 

 

Ramsdens does not offer unsecured high-cost short term credit.

 

Headquartered in Middlesbrough, the Group operates from 157 stores within the UK (including 3 franchised stores) and has a growing online presence.

 

Ramsdens is fully FCA authorised for its pawnbroking and credit broking activities.

 

www.ramsdensplc.com

www.ramsdensforcash.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLVRLISFIF
Date   Source Headline
3rd Jun 20267:00 amRNSInterim Results - six months ended 31 March 2026
6th May 20267:00 amRNSTrading Update
7th Apr 20262:54 pmRNSDirector/PDMR Shareholding
7th Apr 202611:54 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTrading Update
9th Mar 20263:38 pmRNSResult of AGM
9th Mar 20263:38 pmRNSResult of AGM
12th Feb 20261:45 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSNotice of AGM
14th Jan 20267:00 amRNSAnnual Results - year ended 30 September 2025
7th Jan 20267:00 amRNS-RNotice of Annual Results Investor Presentation
12th Dec 20257:00 amRNSAppointment of Nominated Adviser and Broker
24th Nov 20257:00 amRNSDirector/PDMR Shareholding
17th Nov 202510:08 amRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNS-RNotice of Investor Presentation
8th Oct 20257:00 amRNSPre-Close Trading Update
10th Sep 20252:17 pmRNSHolding(s) in Company
21st Aug 20259:35 amRNSHolding(s) in Company
19th Jun 202510:47 amRNSHolding(s) in Company
18th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20257:00 amRNSInterim Results - six months ended 31 March 2025
16th May 20257:00 amRNSNotice of Interim Results & Investor Presentation
2nd May 20257:00 amRNSDirector/PDMR Shareholding
28th Apr 20252:54 pmRNSHolding(s) in Company
24th Apr 20259:47 amRNSDirector/PDMR Shareholding
8th Apr 20257:00 amRNSTrading Update
17th Mar 20254:05 pmRNSChange of Registered Office Address
14th Mar 20253:21 pmRNSDirector/PDMR Shareholding
13th Mar 202510:58 amRNSCSOP update
3rd Mar 20254:27 pmRNSResult of AGM
3rd Mar 20257:00 amRNSAGM Business Update
29th Jan 20257:00 amRNSIssue of Equity, PDMR and Total Voting Rights
23rd Jan 202512:46 pmRNSNotice of AGM
14th Jan 20257:00 amRNSAnnual Results - year ended 30 September 2024
28th Oct 20243:55 pmRNSHolding(s) in Company
11th Oct 20244:31 pmRNSHolding(s) in Company
10th Oct 20247:00 amRNSPre-Close Trading Update and Notice of Results
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSTrading Update
1st Jul 20247:00 amRNSNominated Adviser and Broker
5th Jun 202411:42 amRNSHolding(s) in Company
5th Jun 20247:00 amRNSInterim Results - six months ended 31 March 2024
24th May 202410:51 amRNSHolding(s) in Company
24th May 20247:00 amRNSNotice of Interim Results Investor Presentation
23rd May 20247:00 amRNSForthcoming Board Changes
16th May 20247:00 amRNSNotice of Interim Results
14th May 202412:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.